COPD/ILD Stem Cell Therapy - Chronic Obstructive Pulmonary Disease Treatment
MSC therapy for COPD and interstitial lung disease. Reduces airway inflammation, improves lung function, decreases exacerbation frequency, enhances breathing capacity.
Stem cell therapy addressing chronic airway inflammation and lung tissue damage in COPD/ILD patients.
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial Lung Disease (ILD)
- Emphysema
- Chronic Bronchitis
- Reduces airway inflammation
- Improves FEV1 and FVC metrics
- Decreases acute exacerbation frequency
- Enhances oxygen saturation
- Improves exercise tolerance and quality of life